Found 2 articles for: "Moderate-to-Severe Acne"
Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne
October 2022 | Volume 21 | Issue 10 | Original Article | 1061 | Copyright © October 2022
Background: While topical retinoids are a mainstay of acne treatment, acne can manifest differently in various skin types. The objective of these post hoc analyses from two pooled pha...
Read MoreTazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex
June 2021 | Volume 20 | Issue 6 | Original Article | 608 | Copyright © June 2021
Background: Two identical phase 3 trials (NCT03168321 and NCT03168334) and pooled post hoc analyses have established efficacy and safety of a polymeric tazarotene 0.045% lotion formul...
Read More
